BHST: BioHarvest Sciences, Inc. Price-to-Revenue Ratio

Symbol and logo of brand BioHarvest Sciences, Inc. (BHST)

BioHarvest Sciences (BHST) dominates the cellular biopharming niche, attracting leading scientists with its innovative R&D environment. The price-to-sales multiple on the GURU.Markets website demonstrates market resilience, where 1.00 expresses the metric's value today. Growth is driven by robotic AI bioreactors, while diversification through the production of plant-based components for the food industry minimizes risks and opens access to new sales markets.

BioHarvest (BHST): Price-to-Revenue Ratio from 11/13/2024 to 11/13/2026

Analytical breakdowns for BioHarvest (BHST)

- share price and consensus valuation forecast:
Price Performance Chart bioharvest.com|BHST - Analyst Consensus Forecast
- market capitalization information:
Market Value BioHarvest|BHST - Enterprise Value
- issuer book value statistics:
Net Assets per Share BioHarvest Sciences|BHST - Company Book Value|Market-to-Book Ratio bioharvest.com|BHST - Company Total Assets
- debt obligations and liquidity statistics:
All Debt to Shareholders' Equity Ratio BioHarvest Sciences|BHST - Long-Term Debt to Capital|Short-Term Debt to Capital BioHarvest Sciences Inc|BHST - Company Debts|Debt to Net Assets Ratio BioHarvest|BHST - Company Long-Term Liabilities|Company Short-Term Debt BioHarvest Sciences|Immediate Liquidity bioharvest.com
- net income and valuation ratios data:
BHST - Company Net Income|Company Profit Forecast BioHarvest Sciences|BHST - Price to Earnings Ratio|Market Cap to Future Earnings Ratio BioHarvest Sciences, Inc.|BHST - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation BioHarvest|BHST - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters BioHarvest Sciences|BHST - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months bioharvest.com|BHST - Earnings growth in current year|Consensus forecast of earnings per share growth for next year BioHarvest Sciences
- total revenue and sales volume data:
BHST - Revenue and Sales Volume|Company Expected Sales Volume bioharvest.com|BHST - Price-to-Revenue Ratio|Market Cap to Projected Revenue BioHarvest
Fundamental company analysis:bioharvest.com, BHST
Finished products of BioHarvest

Assessing the investment reliability of equity assets requires comparing a business's market value with its actual ability to generate income. The market capitalization-to-revenue ratio measures the market's willingness to pay a premium for sales volumes, which for BioHarvest Sciences (BHST) highlights the value of exclusive ownership of cell-growing technology coupled with outsourced logistics; analyzing the price/sales multiple allows for the determination of whether the asset is overbought relative to historical expectations.

Who BioHarvest Sciences competes with

HLN (haleon.com) - Market Capitalization-to-Revenue Ratio|P/S Multiple KVUE (Kenvue)|Verona Pharma PLC - Price-to-Revenue Ratio|Jyong Biotech Corp - P/S Multiple|Price-to-Revenue Coefficient Ligand Corp LGND|Amneal Pharmaceuticals (AMRX) - Price-to-Revenue Ratio|Price to Sales perrigo.com (PRGO)|ALVO (Alvotech SA) - P/S Multiple|LQDA: Market Capitalization-to-Revenue Ratio|P/S Multiple GLPG|P/S Multiple ANI Pharmaceuticals Corp (ANIP)|Price-to-Revenue Ratio MannKind Corporation MNKD|Market Capitalization-to-Revenue Ratio AMPH|PCRX: Market Cap to Revenue|SPRY: Price-to-Revenue Ratio|TBPH: P/S Multiple|Price to Sales Aquestive Corp (AQST)|Price-to-Revenue Ratio scPharmaceuticals, Inc.|Tectonic (TECX) - Price-to-Revenue Coefficient|Market Cap to Revenue TNXP (Tonix Pharmaceuticals Holding Corp.)|Market Cap to Sales Volume SXTC|Eupraxia Pharmaceuticals Inc. - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio EXOZ|ORMP - Price-to-Revenue Ratio|Price-to-Revenue Coefficient Entera Bio Ltd. ENTX|HYFT: P/S Multiple|Market Cap to Revenue ABVC BioPharma Inc.|CPIX (Cumberland Pharma) - P/S Multiple|Quantum BioPharma Corp (QNTM) - Price-to-Revenue Coefficient|P/S Multiple FGEN|TELO - Price to Sales|Price-to-Revenue Ratio Rani Therapeutics Holdings, Inc. RANI|SNYR: Market Cap to Revenue Ratio|Rallybio Corp. - P/S Multiple|Lexaria Bioscience (LEXX) - Market Cap to Revenue|PULM: P/S Multiple|Price to Sales Pheton Holdings (PTHL)|Price-to-Revenue Ratio Aptorum Group Ltd|Lyra Therapeutics Inc. (LYRA) - Price-to-Revenue Coefficient|P/S Multiple IBO|Price-to-Revenue Ratio TNFA (tnfpharma.com)|P/S Multiple YCBD (cbdMD)|Market Capitalization-to-Revenue Ratio PRFX|CYTO - Price-to-Revenue Ratio|Price-to-Revenue Coefficient Lipella Pharmaceuticals Inc LIPO|OPTN (Optinose) - Market Cap to Revenue|PIRS: Market Cap to Sales Volume|Price-to-Revenue Ratio Procaps Group S.A.|petrospharma.com - Price-to-Sales Ratio|P/S Multiple QLI|SLRN (Acelyrin Inc.) - Market Capitalization-to-Revenue Ratio|P/S Multiple TFFP (TFF Pharma)